RU99111774A - Применение lh-rh-антагонистов в качестве диагностического средства - Google Patents
Применение lh-rh-антагонистов в качестве диагностического средстваInfo
- Publication number
- RU99111774A RU99111774A RU99111774/14A RU99111774A RU99111774A RU 99111774 A RU99111774 A RU 99111774A RU 99111774/14 A RU99111774/14 A RU 99111774/14A RU 99111774 A RU99111774 A RU 99111774A RU 99111774 A RU99111774 A RU 99111774A
- Authority
- RU
- Russia
- Prior art keywords
- antagonists
- hysteroscopy
- cetrorelix
- antagonist
- application
- Prior art date
Links
- XLXSAKCOAKORKW-UHFFFAOYSA-N Gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 title claims 3
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 title claims 3
- 108010084340 Gonadotropin-Releasing Hormone Proteins 0.000 title claims 3
- 230000003042 antagnostic Effects 0.000 title claims 3
- 239000005557 antagonist Substances 0.000 title claims 3
- SBNPWPIBESPSIF-MHWMIDJBSA-N cetrorelix Chemical compound C([C@@H](C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 SBNPWPIBESPSIF-MHWMIDJBSA-N 0.000 claims 4
- 229960003230 cetrorelix Drugs 0.000 claims 4
- 239000002474 gonadorelin antagonist Substances 0.000 claims 3
- 230000037396 body weight Effects 0.000 claims 2
- 206010046798 Uterine leiomyoma Diseases 0.000 claims 1
- 201000006828 endometrial hyperplasia Diseases 0.000 claims 1
- 201000009273 endometriosis Diseases 0.000 claims 1
- 201000010260 leiomyoma Diseases 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
Claims (5)
1. Применение LH-RH-антагонистов в качестве диагностического средства для улучшения эффективности гистероскопии.
2. Применение по п. 1, отличающееся тем, что в качестве LН-RН-антагониста используют Cetrorelix.
3. Применение по одному из пп. 1 и 2, отличающееся тем, что LH-RH-антагонист, в частности Cetrorelix, дают одноразовой дозой 0,1 - 2 мг на кг веса тела перед гистероскопией и/или для подготовки к операции.
4. Применение по одному из пп. 1 и 2, отличающееся тем, что LH-RH-антагонист, в частности Cetrorelix, дают перед гистероскопией и/или для подготовки к операции многократной дозировкой 0,01 - 0,5 мг на кг веса тела, предпочтительно распределенной на 1 - 14 дн.
5. Применение LH-RH-антагонистов, в частности Cetrorelix, при гистероскопии в комбинации с последующим лечением эндометриоза, удалением миомы или эндометриальной гиперплазией.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19644994A DE19644994A1 (de) | 1996-10-30 | 1996-10-30 | Diagnostisches Mittel |
| DE19644994.4 | 1996-10-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU99111774A true RU99111774A (ru) | 2001-03-27 |
| RU2193414C2 RU2193414C2 (ru) | 2002-11-27 |
Family
ID=7810344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU99111774/14A RU2193414C2 (ru) | 1996-10-30 | 1997-10-23 | Применение lh-rh-антагонистов в качестве диагностического средства |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6106805A (ru) |
| EP (1) | EP0938330B1 (ru) |
| JP (1) | JP2001502702A (ru) |
| AR (1) | AR008516A1 (ru) |
| AT (1) | ATE212856T1 (ru) |
| AU (1) | AU717538B2 (ru) |
| BR (1) | BR9712456A (ru) |
| CA (1) | CA2219641C (ru) |
| DE (2) | DE19644994A1 (ru) |
| DK (1) | DK0938330T3 (ru) |
| ES (1) | ES2172818T3 (ru) |
| HU (1) | HUP9904642A3 (ru) |
| IL (1) | IL129293A (ru) |
| NO (1) | NO323690B1 (ru) |
| NZ (1) | NZ335065A (ru) |
| PL (1) | PL188998B1 (ru) |
| PT (1) | PT938330E (ru) |
| RU (1) | RU2193414C2 (ru) |
| TW (1) | TW534817B (ru) |
| WO (1) | WO1998018482A1 (ru) |
| ZA (1) | ZA979693B (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
| DE4342091A1 (de) * | 1993-12-09 | 1995-06-14 | Asta Medica Ag | Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten |
| US5574011A (en) * | 1995-04-04 | 1996-11-12 | Tien; Henry C. | Compositions and methods for the treatment of male-pattern baldness |
-
1996
- 1996-10-30 DE DE19644994A patent/DE19644994A1/de not_active Withdrawn
-
1997
- 1997-10-23 HU HU9904642A patent/HUP9904642A3/hu unknown
- 1997-10-23 PL PL97333174A patent/PL188998B1/pl not_active IP Right Cessation
- 1997-10-23 DK DK97947017T patent/DK0938330T3/da active
- 1997-10-23 BR BR9712456-7A patent/BR9712456A/pt not_active IP Right Cessation
- 1997-10-23 NZ NZ335065A patent/NZ335065A/en unknown
- 1997-10-23 AT AT97947017T patent/ATE212856T1/de not_active IP Right Cessation
- 1997-10-23 PT PT97947017T patent/PT938330E/pt unknown
- 1997-10-23 DE DE59706334T patent/DE59706334D1/de not_active Expired - Fee Related
- 1997-10-23 WO PCT/DE1997/002456 patent/WO1998018482A1/de active IP Right Grant
- 1997-10-23 EP EP97947017A patent/EP0938330B1/de not_active Expired - Lifetime
- 1997-10-23 RU RU99111774/14A patent/RU2193414C2/ru not_active IP Right Cessation
- 1997-10-23 IL IL12929397A patent/IL129293A/xx not_active IP Right Cessation
- 1997-10-23 AU AU52217/98A patent/AU717538B2/en not_active Ceased
- 1997-10-23 JP JP10519885A patent/JP2001502702A/ja not_active Ceased
- 1997-10-23 ES ES97947017T patent/ES2172818T3/es not_active Expired - Lifetime
- 1997-10-27 TW TW086115895A patent/TW534817B/zh not_active IP Right Cessation
- 1997-10-28 CA CA002219641A patent/CA2219641C/en not_active Expired - Fee Related
- 1997-10-29 ZA ZA9709693A patent/ZA979693B/xx unknown
- 1997-10-30 AR ARP970105058A patent/AR008516A1/es not_active Application Discontinuation
- 1997-10-30 US US08/961,085 patent/US6106805A/en not_active Expired - Fee Related
-
1999
- 1999-04-22 NO NO19991920A patent/NO323690B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
| EE9800173A (et) | Gonadotropiini riliisinghormooni antagonistid | |
| MX9804850A (es) | Antagonistas de hormona liberadora de gonadotropina. | |
| WO1995031985A3 (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
| CA2363990A1 (en) | Use of glycyrrhizin in the treatment of mastitis | |
| RU94046068A (ru) | Применение конкурентных антагонистов прогестерона для контрацепции, новые соединения ряда конкурентных антагонистов прогестерона | |
| CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
| ES2074769T3 (es) | Procedimiento para la elaboracion de un preparado farmaceutico con, al menos, dos principios activos diferentes y uso de un preparado de este tipo. | |
| EA199900499A1 (ru) | Фармацевтическая композиция, включающая соединение, обладающее анти-xa активностью, и соединение антагонист агрегации тромбоцитов | |
| EA200100799A1 (ru) | Антагонисты фактора опухолевого некроза и их применение при эндометриозе | |
| CA2378613A1 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
| RU2002105377A (ru) | Ксенон-антагонист nmda | |
| MX9706957A (es) | Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina. | |
| EP0663835A1 (en) | USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS. | |
| JP2004537500A5 (ru) | ||
| CA2291160A1 (en) | Combination therapy for modulating the human sexual response | |
| CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
| RU93047023A (ru) | Производные имидазола-антагонисты ангиотензина-11, их получение и терапевтическое применение | |
| RU99111774A (ru) | Применение lh-rh-антагонистов в качестве диагностического средства | |
| GR3031042T3 (en) | Use of 5-ht4-receptor antagonists in the treatment of atrial fibrillation, including the prevention of stroke | |
| MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
| CA2290739A1 (en) | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
| ES2162813T3 (es) | Uso de 3,5-diamino-6-(2,3-diclorofenil)-1,2,4-triazina en la preparacion de un farmaco para el tratamiento de ciertos tipos de dolor y edema. | |
| CA2219641A1 (en) | Diagnostic composition | |
| 魏赞美 | Clinical observation on therapeutic effect of acupuncture at zusanli for leukopenia |